Open AccessDifference in Biomarkers Between COVID-19 Patients and Other Pulmonary Infection Patients
Author(s) -
Jingyi Dai,
Yingrong Du,
Jianpeng Gao,
Jun Zhao,
Lin Wang,
Ying Huang,
Jia-Wei Xia,
Yu Luo,
Shenghao Li,
Edward McNeil
Publication year - 2020
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s257936
Subject(s) - medicine , covid-19 , cohort , prothrombin time , medical record , retrospective cohort study , disease , infectious disease (medical specialty)
The pandemic due to the novel coronavirus disease 2019 (COVID-19) has resulted in an increasing number of patients need to be tested. We aimed to determine if the use of integrated laboratory data can discriminate COVID-19 patients from other pulmonary infection patients.